BMC Neurology (Jun 2023)
Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
- Noa Bregman,
- Tamara Shiner,
- Gitit Kavé,
- Roy Alcalay,
- Mali Gana-Weisz,
- Orly Goldstein,
- Tal Glinka,
- Orna Aizenstein,
- Dafna Ben Bashat,
- Yifat Alcalay,
- Anat Mirelman,
- Avner Thaler,
- Nir Giladi,
- Nurit Omer
Affiliations
- Noa Bregman
- Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center
- Tamara Shiner
- Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center
- Gitit Kavé
- Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center
- Roy Alcalay
- Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center
- Mali Gana-Weisz
- Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center
- Orly Goldstein
- Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center
- Tal Glinka
- Laboratory of biomarkers and genomic of neurodegeneration, Tel-Aviv Medical Center
- Orna Aizenstein
- Sagol Brain Institute, Wohl Institute for Advanced Imaging, Sourasky Medical Center
- Dafna Ben Bashat
- Sagol School of Neuroscience, Tel-Aviv University
- Yifat Alcalay
- Sackler School of Medicine, Tel-Aviv University
- Anat Mirelman
- Sackler School of Medicine, Tel-Aviv University
- Avner Thaler
- Sackler School of Medicine, Tel-Aviv University
- Nir Giladi
- Sackler School of Medicine, Tel-Aviv University
- Nurit Omer
- Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center
- DOI
- https://doi.org/10.1186/s12883-023-03272-w
- Journal volume & issue
-
Vol. 23,
no. 1
pp. 1 – 1
Abstract
No abstracts available.